Breast cancer recurrence remains low, even after 10 years, with radiotherapy tailored to patient's individual risk

The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their individual risk following chemotherapy and surgery. These are the findings of a 10-year study presented at the 15th European Breast Cancer Conference (EBCC15) in Barcelona on March 25.